Search published articles


Showing 22 results for Ahmadi
Evaluation of blood parameters in the management of patients with thyroid disease
Abazar Yari , Morteza Ahmadi , Mahdieh Mehrpouri ,
Volume 18, Issue 5 (Sep-Oct 2024)
Abstract
Background: Thyroid hormones play a critical role in hematopoiesis, and thyroid disorders such as hypothyroidism and hyperthyroidism can affect blood parameters. Therefore, this study aimed to evaluate the effect of thyroid dysfunction on various blood parameters.
Methods: This case-control study included 194 subjects who were classified into three groups based on TSH levels: hypothyroid (n=70), hyperthyroid (n=56), and control (n=68). Conditions that affect blood parameters, including pregnancy, inherited or acquired red blood cell abnormalities, chronic inflammatory diseases, evidence of nutritional deficiencies, and underlying diseases such as cancer, as well as patients unwilling to participate in the study, were excluded. Hematological parameters were measured using a cell counter, and the results were analyzed using SPSS software.
Results: The results showed that 78% of the participants were female and 22% were male, aged 4 to 89 years. The analyses revealed that RBC, Hb, HCT, WBC count, and WBC differential count were significantly different between the three groups (P-value <0.05), but the differences were not significant for MCV, MCH, MCHC, RDW, PLT, and MPV (P-value >0.05). Correlation analysis indicated a significant correlation between TSH and Hb, HCT, WBC, PLT, neutrophils, lymphocytes, monocytes, and eosinophils (P<0.05).
Conclusion: Since thyroid hormones play a critical role in hematopoiesis, thyroid dysfunction can affect many hematological parameters. Therefore, the management of patients with thyroid disease should include the CBC test. In addition, patients with poor responses to anemia treatment may have an underlying thyroid disorder.


Cloning, expression, and purification of recombinant Enterotoxin B and cholera toxin B fusion protein in Lactobacillus plantarum
Fatemeh Maghsood Ahmadi , Arash Mahboubi , Farzaneh Hosseini , Davoud Esmaeili , Bahareh Hajikhani ,
Volume 19, Issue 5 (Sep-Oct 2025)
Abstract
Background: Lactic acid bacteria (LAB) are promising platforms for mucosal vaccine development. Staphylococcus aureus enterotoxin B (SEB), a potent superantigen, is associated with food poisoning and toxic shock syndrome. Similarly, cholera toxin is the primary to widespread virulence factor in Vibrio cholerae infections, with its B subunit (CTB) serving as a well-established immune adjuvant that enhances antigen-specific responses in recombinant vaccines. This study aimed to engineer recombinant Lactobacillus plantarum as a dual-purpose vaccine candidate targeting V. cholerae and S. aureus by expressing CTB and SEB antigens.
Methods: A modified gene sequence encoding SEB (Lacking superantigenic activity) and CTB was successfully designed, synthesized, and cloned for secretory expression in L. plantarum. The resulting recombinant protein, tagged with His, was purified using Ni-NTA agarose ion-exchange chromatography and confirmed with Western blot analysis.
Results: Enzyme digestion and PCR analysis confirmed successful cloning of the SEB-CTB fusion gene into the pBlueScript II SK (+) and pNZ7021 expression vectors, as evidenced by the expected band on agarose gel. SDS-PAGE revealed a ~49 kDa protein band, indicating expression of the recombinant rSEB-CTB protein, which was further validated by Western blot using an anti-His tag antibody.
Conclusion: The construct LP-pNZ7021–SP-seb-ctxB may be a promising candidate for recombinant vaccine development targeting V. cholerae (Cholera toxin-producing) and S. aureus (SEB-producing), providing dual protection against both pathogens.
 

Page 2 from 2